Clinical Pharmacology and Drug Toxicity Practice Questions

Q: The International Olympic Committee has prohibited the use of all of the following substances in sports except:

Salbutamol. The World Anti-Doping Agency (WADA) and the International Olympic Committee (IOC) maintain a list of prohibited substances to ensure fair play and athlete safety [1]. **Correct Answer: A. Salbutamol** Salbutamol is a selective $\beta_2$-agonist used primarily for bronchodilation [4]. While most stimulants and anabolic agents are banned, **Salbutamol is permitted via inhalation** (up to a specific threshold, typically 1600 micrograms over 24 hours) to allow athletes with exercise-induced bronchospasm or asthma to compete. However, oral or systemic administration remains prohibited as it can have anabolic effects at high doses. **Explanation of Incorrect Options:** * **B. Furosemide:** This is a loop diuretic. Diuretics are banned because they act as **masking agents**, diluting the urine to hide the presence of other performance-enhancing drugs [1]. They are also used for rapid weight loss in sports with weight categories (e.g., wrestling, boxing). * **C. Estrogen (Anti-estrogenic agents):** While estrogen itself isn't typically performance-enhancing for men, **Selective Estrogen Receptor Modulators (SERMs)** and aromatase inhibitors are banned. They are used by athletes to mitigate the side effects (like gynecomastia) of anabolic steroid abuse. * **D. Nandrolone:** This is an **Anabolic Androgenic Steroid (AAS)** [3]. It is strictly prohibited as it increases muscle mass, strength, and erythropoiesis, providing an unfair physical advantage. **High-Yield NEET-PG Pearls:** * **Beta-blockers:** Prohibited only in specific sports requiring precision (e.g., Archery, Shooting, Billiards) because they reduce tremors. * **Erythropoietin (EPO):** Banned because it increases red cell count, enhancing oxygen-carrying capacity (Blood Doping) [2]. * **Glucocorticoids:** Prohibited in-competition when administered via oral, intravenous, intramuscular, or rectal routes.

Q: Which of the following is NOT useful for the management of hypermagnesemia?

Amiloride. Hypermagnesemia (Serum $Mg^{2+} > 2.5$ mg/dL) is a rare but life-threatening electrolyte imbalance, usually occurring in patients with renal failure or those receiving excessive magnesium therapy (e.g., for eclampsia). **Why Amiloride is the Correct Answer:** Amiloride is a **potassium-sparing diuretic** that works by inhibiting the Epithelial Sodium Channels (ENaC) in the distal tubule [2]. Importantly, amiloride and other potassium-sparing diuretics (like triamterene) actually **decrease the excretion of magnesium**. Using amiloride would worsen hypermagnesemia, making it contraindicated in this condition. **Analysis of Incorrect Options:** * **Calcium Gluconate:** This is the **first-line emergency treatment**. Calcium acts as a direct physiological antagonist to magnesium at the neuromuscular junction and cardiac membrane, reversing life-threatening respiratory depression or arrhythmias. * **Intravenous Fluids:** Normal saline (0.9% NaCl) combined with **loop diuretics** (like Furosemide) is used to promote "forced diuresis." This increases the renal clearance of magnesium in patients with preserved renal function [1]. * **Magnesium-free Enema:** In cases of magnesium ingestion (e.g., laxative overdose), removing unabsorbed magnesium from the GI tract using magnesium-free solutions or enemas helps prevent further systemic absorption. **NEET-PG High-Yield Pearls:** 1. **Clinical Presentation:** Loss of deep tendon reflexes (DTRs) is the earliest sign ($7–10$ mEq/L), followed by respiratory paralysis and cardiac arrest ($>12$ mEq/L). 2. **Antidote:** IV Calcium Gluconate (10%) is the specific antidote for magnesium toxicity. 3. **Renal Failure:** In patients with severe renal impairment and symptomatic hypermagnesemia, **hemodialysis** is the definitive management. 4. **Drug Association:** Loop diuretics (Furosemide) *increase* Mg excretion [1], while Potassium-sparing diuretics (Amiloride) *decrease* it.

Q: A 50-year-old male, suffering from renal failure, underwent a kidney transplant and was prescribed a nucleotide derivative post-transplant. Which nucleotide derivative is of therapeutic importance in this organ transplant?

Azathioprine. **Explanation:** The correct answer is **Azathioprine**. **Why Azathioprine is correct:** Azathioprine is a prodrug that is non-enzymatically converted into **6-mercaptopurine (6-MP)**, a purine analogue (nucleotide derivative). It acts as an immunosuppressant by inhibiting purine synthesis, which specifically prevents the proliferation of T and B lymphocytes. In the context of organ transplantation (like the kidney transplant mentioned), it is used to prevent **acute graft rejection** by suppressing the recipient's immune response against the donor organ. **Analysis of Incorrect Options:** * **5-Fluorouracil (5-FU):** This is a pyrimidine analogue used primarily as a cytotoxic chemotherapy agent for solid tumors (e.g., colorectal cancer), not for immunosuppression in transplants. * **Cytarabine (Ara-C):** This is also a pyrimidine analogue (cytosine arabinoside) used mainly in the treatment of hematological malignancies like Acute Myeloid Leukemia (AML). * **Allopurinol:** While it is a purine analogue, it is a **xanthine oxidase inhibitor** used to treat gout and hyperuricemia. It is not an immunosuppressant. **NEET-PG High-Yield Pearls:** * **Drug Interaction:** Allopurinol inhibits xanthine oxidase, the enzyme responsible for metabolizing 6-MP. If a patient on Azathioprine is given Allopurinol, the levels of 6-MP rise significantly, leading to severe **bone marrow toxicity**. The dose of Azathioprine must be reduced by 75% in such cases. * **Pharmacogenomics:** Patients with a genetic deficiency of the enzyme **TPMT (Thiopurine Methyltransferase)** are at high risk of life-threatening myelosuppression when taking Azathioprine. * **Side Effects:** The most common side effect is bone marrow suppression (leukopenia).

Q: After taking certain medications, a patient noticed yellowing of the eyes. Which of the following most often causes cholestatic jaundice?

Erythromycin estolate. **Explanation:** The correct answer is **Erythromycin estolate**. **1. Why Erythromycin estolate is correct:** Cholestatic jaundice is a classic, well-documented hypersensitivity reaction specifically associated with the **estolate salt** of Erythromycin. It typically manifests 10–20 days after starting therapy. The mechanism involves a combination of direct hepatotoxicity and an immune-mediated (allergic) reaction, leading to bile stasis. Patients present with upper abdominal pain, fever, and yellowing of the sclera (icterus), mimicking acute cholecystitis. Interestingly, other salts of erythromycin (like stearate or succinate) rarely cause this condition. **2. Analysis of Incorrect Options:** * **A. Isoniazid (INH):** Causes **hepatocellular necrosis** (elevated ALT/AST) rather than cholestasis. It is metabolized to acetylhydrazine, which causes direct liver injury. * **C. Pyrazinamide:** This is the **most hepatotoxic** first-line anti-tubercular drug. Like INH, it typically causes dose-dependent hepatocellular damage. * **D. Ethionamide:** A second-line anti-tubercular drug that is structurally related to INH; it causes hepatitis in about 5% of patients but is not the classic cause of cholestatic jaundice compared to erythromycin estolate. **3. NEET-PG High-Yield Pearls:** * **Cholestatic Jaundice triad:** Erythromycin estolate, Chlorpromazine, and Methyltestosterone (Anabolic steroids). * **Oral Contraceptives:** Can also cause cholestasis but are usually associated with "painless" jaundice. * **Drug of Choice:** Erythromycin is the drug of choice for atypical pneumonias (Legionella) and in penicillin-allergic patients for syphilis/gonorrhea. * **Prokinetic effect:** Erythromycin acts on **motilin receptors**, making it useful for diabetic gastroparesis.

Q: What is the antidote for benzodiazepine toxicity?

Flumazenil. **Explanation:** **Correct Answer: A. Flumazenil** Benzodiazepines (BZDs) act by enhancing the effect of GABA at the **GABA-A receptor**, specifically binding to a unique site that increases the frequency of chloride channel opening [2]. **Flumazenil** is a specific **competitive antagonist** at the benzodiazepine binding site on the GABA-A receptor complex [1], [2]. It rapidly reverses the sedative effects of BZDs [2] but is less effective at reversing respiratory depression. **Incorrect Options:** * **B. Naloxone:** A competitive opioid antagonist used specifically for acute opioid overdose (reverses respiratory depression). * **C. Naltrexone:** A long-acting opioid antagonist primarily used in the management of opioid and alcohol dependence to prevent relapse. * **D. Dimercaprol (BAL):** A chelating agent used in the treatment of heavy metal poisoning, such as arsenic, mercury, and lead. **Clinical Pearls for NEET-PG:** 1. **The Seizure Risk:** The most critical contraindication for Flumazenil is in patients with **chronic BZD use** or **Tricyclic Antidepressant (TCA) overdose**, as it can precipitate life-threatening withdrawal seizures [1]. 2. **Short Half-life:** Flumazenil has a shorter half-life (approx. 1 hour) than most benzodiazepines. Therefore, **re-sedation** can occur, and repeated doses or an infusion may be necessary. 3. **Mechanism Check:** Remember, BZDs increase the **frequency** of Cl⁻ channel opening, while Barbiturates increase the **duration** [2]. Flumazenil does *not* reverse barbiturate toxicity [2].

Q: Methemoglobinemia may be caused by the following agents, EXCEPT:

Phenytoin. **Explanation:** **Methemoglobinemia** occurs when the iron in hemoglobin is oxidized from the ferrous state ($Fe^{2+}$) to the **ferric state ($Fe^{3+}$)**. Ferric iron cannot bind oxygen, and it also increases the oxygen affinity of the remaining ferrous heme, leading to a leftward shift of the oxygen-dissociation curve and tissue hypoxia. **Why Phenytoin is the Correct Answer:** **Phenytoin** is an antiepileptic drug primarily associated with side effects like gingival hyperplasia, hirsutism, megaloblastic anemia (due to folate deficiency), and Stevens-Johnson Syndrome. It **does not** possess the oxidative potential required to convert hemoglobin to methemoglobin. **Analysis of Incorrect Options (Agents that cause Methemoglobinemia):** * **Sulfonamides:** These are classic oxidizing agents. They induce oxidative stress on red blood cells, leading to methemoglobin formation, especially in individuals with G6PD deficiency. * **Phenacetin:** An older analgesic (now largely withdrawn) known for causing nephropathy and oxidative hemolysis/methemoglobinemia. * **Phenazopyridine:** Used as a urinary analgesic, it is a potent oxidizing agent that can cause methemoglobinemia even in therapeutic doses, particularly in patients with renal impairment. **High-Yield Clinical Pearls for NEET-PG:** 1. **Clinical Presentation:** Patients present with "Chocolate-colored blood" and central cyanosis that does not improve with 100% oxygen. 2. **Antidote:** The drug of choice is **Methylene Blue** (acts as an electron acceptor for NADPH-methemoglobin reductase). 3. **Other Common Triggers:** Nitrites/Nitrates, Local anesthetics (Prilocaine, Benzocaine), Dapsone, and Nitrofurantoin. 4. **Diagnosis:** A "Saturation Gap" is often seen (difference between $SaO_2$ on pulse oximetry and $SaO_2$ on ABG).

Q: Which of the following medications can cause Gynaecomastia?

Cimetidine. **Explanation:** **Gynaecomastia** (enlargement of male breast tissue) occurs due to an imbalance between estrogenic and androgenic effects. **Why Cimetidine is correct:** **Cimetidine**, an H2-receptor antagonist, is a classic cause of drug-induced gynaecomastia. It acts via two primary mechanisms: 1. **Anti-androgenic effect:** It binds to androgen receptors and acts as an antagonist, blocking the action of dihydrotestosterone (DHT). 2. **Inhibition of Metabolism:** It inhibits Cytochrome P450 enzymes, which can lead to decreased degradation of estradiol. 3. It also causes a transient increase in serum **prolactin** levels. **Analysis of Incorrect Options:** * **A. Flutamide:** While Flutamide is a potent anti-androgen used in prostate cancer and *can* cause gynaecomastia, it is generally considered a therapeutic effect/side effect of hormonal manipulation. In the context of standard NEET-PG questions, Cimetidine is the "textbook" classic example of a non-hormonal drug causing this side effect. (Note: If this were a multiple-choice "all of the above" style, Flutamide would be included). * **C. Pyrazinamide:** This is an anti-tubercular drug known for causing hyperuricemia (gout) and hepatotoxicity, but not gynaecomastia. (Note: **Isoniazid** is the ATT drug that causes gynaecomastia). * **D. Methotrexate:** This is a folate antagonist used in cancer and autoimmune diseases. Its primary toxicities are bone marrow suppression, mucosal ulceration, and hepatotoxicity. **High-Yield Clinical Pearls for NEET-PG:** To remember the common drugs causing gynaecomastia, use the mnemonic **"DISCO"**: * **D**igoxin * **I**soniazid * **S**pironolactone (Most common cause) * **C**imetidine * **O**estrogens / **O**pioids **Other notable mentions:** Ketoconazole (inhibits steroid synthesis) and Risperidone (via hyperprolactinemia).

Q: All of the following are examples of time-dependent late adverse drug reactions except?

Nitrate-induced headache. ### Explanation Adverse drug reactions (ADRs) are often classified using the **Rawlins and Thompson** system (Type A to E). To answer this question, we must distinguish between **Type A (Augmented)** and **Type D (Delayed/Late)** reactions. **1. Why "Nitrate-induced headache" is the correct answer:** Nitrate-induced headache is a **Type A (Augmented)** reaction. It is a predictable, dose-dependent extension of the drug’s primary pharmacological action (vasodilation). Crucially, it occurs **immediately** after administration and often exhibits **tachyphylaxis** (tolerance), meaning the headache typically diminishes with continued use. It is not a "late" or "delayed" reaction. **2. Analysis of Incorrect Options (Examples of Type D/Late Reactions):** Type D reactions are "Delayed" or "Late" because they occur after prolonged exposure or even years after treatment. * **Glucocorticoid-induced osteoporosis:** This is a classic time-dependent ADR resulting from chronic suppression of osteoblast activity and calcium malabsorption over months/years. * **Chloroquine-induced retinopathy:** This occurs due to the cumulative dose and long-term deposition of the drug in melanin-rich retinal tissues. * **Amiodarone-induced tissue phospholipid deposition:** Amiodarone has a very long half-life and causes cumulative toxicity, leading to phospholipidosis in tissues like the lungs, liver, and cornea over long-term therapy. ### High-Yield NEET-PG Pearls: * **Type A (Augmented):** Common, predictable, low mortality (e.g., Postural hypotension with Alpha-blockers). * **Type B (Bizarre):** Unpredictable, idiosyncratic, high mortality (e.g., Anaphylaxis with Penicillin). * **Type C (Chronic):** Occurs with long-term use (e.g., Analgesic nephropathy). * **Type D (Delayed):** Includes teratogenesis (e.g., Thalidomide) and carcinogenesis. * **Type E (End of use):** Withdrawal symptoms (e.g., Seizures on stopping Benzodiazepines).

Q: Purple toe syndrome is associated with which of the following drugs?

Warfarin. **Explanation:** **Purple Toe Syndrome** is a rare but classic clinical complication associated with **Warfarin** therapy. 1. **Why Warfarin is correct:** The underlying mechanism is believed to be **cholesterol microembolization**. Warfarin-induced anticoagulation can cause the friable atherosclerotic plaques in the aorta or proximal arteries to bleed or destabilize. This releases small cholesterol crystals that travel distally and lodge in the small capillaries of the toes, leading to livedo reticularis, pain, and a characteristic purple-blue discoloration. It typically occurs 3 to 8 weeks after starting therapy. 2. **Why the other options are incorrect:** * **Phenytoin:** Known for causing gingival hyperplasia, hirsutism, and fetal hydantoin syndrome, but not peripheral embolic phenomena. * **Theophylline:** Toxicity primarily manifests as gastrointestinal upset, seizures, and cardiac arrhythmias due to its narrow therapeutic index. * **Thalidomide:** Famous for its teratogenic effect (**Phocomelia** or seal-like limbs). While it can cause peripheral neuropathy, it does not cause purple toe syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Warfarin-induced Skin Necrosis:** Another dermatological emergency caused by Warfarin, occurring much earlier (days 3–10) due to a rapid decline in **Protein C** levels, leading to a transient hypercoagulable state. * **Management:** If purple toe syndrome occurs, Warfarin must be discontinued. * **Antidote:** For Warfarin overdose, use **Vitamin K** (slow) or **Prothrombin Complex Concentrate (PCC)/Fresh Frozen Plasma** (rapid). * **Teratogenicity:** Warfarin is contraindicated in pregnancy as it causes **Chondrodysplasia punctata** (stippled epiphyses and nasal hypoplasia).

Q: All of the following are features of atropine poisoning except?

Hypothermia. ### Explanation **1. Why Hypothermia is the Correct Answer:** Atropine is a competitive antagonist of muscarinic receptors. In atropine poisoning, there is a complete blockade of **M3 receptors** on sweat glands. This leads to the suppression of sweating (anhidrosis), which is the body’s primary mechanism for heat dissipation. Consequently, the body temperature rises significantly, leading to **Hyperthermia** (often called "Atropine fever"), especially in children. Therefore, **Hypothermia** is not a feature of atropine poisoning; it is the opposite of what occurs. **2. Analysis of Incorrect Options:** * **Mydriasis (Option A):** Atropine blocks M3 receptors in the sphincter pupillae muscle, leading to passive, fixed mydriasis (dilated pupils) and cycloplegia (loss of accommodation). * **Hallucinations (Option B):** Atropine is a tertiary amine that crosses the blood-brain barrier. Central muscarinic blockade leads to CNS excitation, resulting in restlessness, disorientation, and vivid visual hallucinations. * **Coma (Option D):** While initial poisoning causes CNS stimulation, severe toxicity leads to progressive CNS depression, eventually resulting in coma and respiratory failure. **3. Clinical Pearls for NEET-PG:** To remember the clinical features of Atropine poisoning, use the classic mnemonic: * **Red as a beet:** Flushing (cutaneous vasodilation) * **Dry as a bone:** Anhidrosis and dry mouth * **Hot as a hare:** **Hyperthermia** * **Blind as a bat:** Mydriasis and cycloplegia * **Mad as a hatter:** Delirium and hallucinations * **Full as a flask:** Urinary retention **High-Yield Fact:** The specific antidote for atropine poisoning is **Physostigmine** (a tertiary acetylcholinesterase inhibitor), as it can cross the blood-brain barrier to reverse both central and peripheral symptoms.

Question 1

The International Olympic Committee has prohibited the use of all of the following substances in sports except:

Accepted Answer

Salbutamol

Answer

Furosemide

Answer

Estrogen

Answer

Nandrolone

Question 2

Which of the following is NOT useful for the management of hypermagnesemia?

Accepted Answer

Amiloride

Answer

Magnesium-free enema

Answer

Intravenous fluids

Answer

Calcium gluconate

Question 3

A 50-year-old male, suffering from renal failure, underwent a kidney transplant and was prescribed a nucleotide derivative post-transplant. Which nucleotide derivative is of therapeutic importance in this organ transplant?

Accepted Answer

Azathioprine

Answer

5-Fluorouracil

Answer

Cytarabine

Answer

Allopurinol

Question 4

After taking certain medications, a patient noticed yellowing of the eyes. Which of the following most often causes cholestatic jaundice?

Accepted Answer

Erythromycin estolate

Answer

Isoniazid (INH)

Answer

Pyrazinamide

Answer

Ethionamide

Question 5

What is the antidote for benzodiazepine toxicity?

Accepted Answer

Flumazenil

Answer

Naloxone

Answer

Naltrexone

Answer

Dimercaprol

Question 6

Methemoglobinemia may be caused by the following agents, EXCEPT:

Accepted Answer

Phenytoin

Answer

Sulfonamides

Answer

Phenacetin

Answer

Phenazopyridine

Question 7

Which of the following medications can cause Gynaecomastia?

Accepted Answer

Cimetidine

Answer

Flutamide

Answer

Pyrazinamide

Answer

Methotrexate

Question 8

All of the following are examples of time-dependent late adverse drug reactions except?

Accepted Answer

Nitrate-induced headache

Answer

Glucocorticoid-induced osteoporosis

Answer

Chloroquine-induced retinopathy

Answer

Amiodarone-induced tissue phospholipid deposition

Question 9

Purple toe syndrome is associated with which of the following drugs?

Accepted Answer

Warfarin

Answer

Phenytoin

Answer

Theophylline

Answer

Thalidomide

Question 10

All of the following are features of atropine poisoning except?

Accepted Answer

Hypothermia

Answer

Mydriasis

Answer

Hallucinations

Answer

Coma

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?